These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2464594)

  • 21. Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism.
    Visser TJ; Kaplan MM; Leonard JL; Larsen PR
    J Clin Invest; 1983 Apr; 71(4):992-1002. PubMed ID: 6833498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of iodothyronine-5'-deiodinase.
    Visser TJ
    Biochim Biophys Acta; 1979 Aug; 569(2):302-8. PubMed ID: 476129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and expression of a cDNA for a mammalian type III iodothyronine deiodinase.
    Croteau W; Whittemore SL; Schneider MJ; St Germain DL
    J Biol Chem; 1995 Jul; 270(28):16569-75. PubMed ID: 7622463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activity.
    Nogimori T; Braverman LE; Taurog A; Fang SL; Wright G; Emerson CH
    Endocrinology; 1986 Apr; 118(4):1598-605. PubMed ID: 3948793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of type II iodothyronine deiodinase marks the time that a tissue responds to thyroid hormone-induced metamorphosis in Xenopus laevis.
    Cai L; Brown DD
    Dev Biol; 2004 Feb; 266(1):87-95. PubMed ID: 14729480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The substrate specificity, tissue specificity and regulation of the 5' deiodination systems in rat liver and kidney tissues.
    Kobayashi S; Gao Y; Pittman CS
    Endocrinol Jpn; 1985 Dec; 32(6):781-92. PubMed ID: 3833526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of type I 5'-deiodination of thyroxine and of reverse-triiodothyronine in rat and chicken liver homogenates.
    Rudas P
    Gen Comp Endocrinol; 1986 Sep; 63(3):400-7. PubMed ID: 3557065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of radioiodinated propylthiouracil to rat liver microsomal fractions. Stimulation by substrates for iodothyronine 5'-deiodinase.
    Visser TJ; Van Overmeeren E
    Biochem J; 1979 Oct; 183(1):167-9. PubMed ID: 534480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High affinity of triiodothyronine (T3) for nonphenolic ring deiodinase and high affinity of tetraiodothyroacetic acid (TETRAC) for phenolic ring deiodinase in cultured monkey hepatocarcinoma cells and in rat liver homogenates.
    Sorimachi K; Yasumura Y
    Endocrinol Jpn; 1981 Dec; 28(6):775-83. PubMed ID: 6809451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of rT3 5'-monodeiodination in rat brain: comparison with T4 and T3 5-monodeiodinations.
    Tanaka K; Inada M; Mashio Y; Ishii H; Naito K; Nishikawa M; Takahashi K; Imura H
    Acta Endocrinol (Copenh); 1982 Nov; 101(3):371-6. PubMed ID: 7148334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral cortex responds rapidly to thyroid hormones.
    Leonard JL; Kaplan MM; Visser TJ; Silva JE; Larsen PR
    Science; 1981 Oct; 214(4520):571-3. PubMed ID: 7291997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.
    Diano S; Naftolin F; Goglia F; Horvath TL
    Endocrinology; 1998 Jun; 139(6):2879-84. PubMed ID: 9607797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of 5'-deiodinase of 3,3',5'-triiodothyronine in rat skeletal muscle.
    Tsukahara F; Nomoto T; Maeda M
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):69-74. PubMed ID: 2911942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the antioxidant TK 12627 (Irganox) on monodeiodination and on the levels of messenger ribonucleic acid of 5'-deiodinase type I and spot 14.
    Liang H; Morin O; Burger AG
    Acta Endocrinol (Copenh); 1993 May; 128(5):451-8. PubMed ID: 8317193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of kidney and brown adipose tissue iodothyronine 5'-deiodinases.
    Silva JE; Mellen S; Larsen PR
    Endocrinology; 1987 Aug; 121(2):650-6. PubMed ID: 3595535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodothyronine 5'-deiodinase in brown adipose tissue: thiol activation and propylthiouracil inhibition.
    Goswami A; Rosenberg IN
    Endocrinology; 1986 Aug; 119(2):916-23. PubMed ID: 3732151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate requirement for inactivation of iodothyronine-5'-deiodinase activity by thiouracil.
    Visser TJ; van Overmeeren-Kaptein E
    Biochim Biophys Acta; 1981 Apr; 658(2):202-8. PubMed ID: 7248301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of iodothyronine outer ring and inner ring deiodinase activities in the blue tilapia, Oreochromis aureus.
    Mol KA; Van Der Geyten S; Darras VM; Visser TJ; Kühn ER
    Endocrinology; 1997 May; 138(5):1787-93. PubMed ID: 9112369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
    Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
    Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenouracil derivatives are potent inhibitors of the selenoenzyme type I iodothyronine deiodinase.
    Visser TJ; Kaptein E; Aboul-Enein HY
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1362-7. PubMed ID: 1482352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.